134 related articles for article (PubMed ID: 36737039)
1. Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice.
Hasan MN; Chen J; Matye D; Wang H; Luo W; Gu L; Clayton YD; Du Y; Li T
J Lipid Res; 2023 Mar; 64(3):100340. PubMed ID: 36737039
[TBL] [Abstract][Full Text] [Related]
2. Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis.
Matye DJ; Qin X; Hasan MN; Gu L; Clayton YD; Li F; Li T
Liver Res; 2022 Dec; 6(4):276-283. PubMed ID: 36819659
[TBL] [Abstract][Full Text] [Related]
3. Glycine-β-Muricholic Acid Improves Liver Fibrosis and Gut Barrier Function by Reducing Bile Acid Pool Size and Hydrophobicity in Male
Hasan MN; Chen J; Wang H; Du Y; Clayton YD; Gu L; Li T
Cells; 2023 May; 12(10):. PubMed ID: 37408204
[No Abstract] [Full Text] [Related]
4. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.
Matye DJ; Wang H; Luo W; Sharp RR; Chen C; Gu L; Jones KL; Ding WX; Friedman JE; Li T
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1001-1019. PubMed ID: 33965587
[TBL] [Abstract][Full Text] [Related]
5. Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition.
Li R; Hovingh MV; Koehorst M; de Blaauw P; Verkade HJ; de Boer JF; Kuipers F
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159163. PubMed ID: 35470044
[TBL] [Abstract][Full Text] [Related]
6. Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury.
Truong JK; Bennett AL; Klindt C; Donepudi AC; Malla SR; Pachura KJ; Zaufel A; Moustafa T; Dawson PA; Karpen SJ
J Lipid Res; 2022 Sep; 63(9):100261. PubMed ID: 35934110
[TBL] [Abstract][Full Text] [Related]
7. Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.
de Boer JF; de Vries HD; Palmiotti A; Li R; Doestzada M; Hoogerland JA; Fu J; La Rose AM; Westerterp M; Mulder NL; Hovingh MV; Koehorst M; Kloosterhuis NJ; Wolters JC; Bloks VW; Haas JT; Dombrowicz D; Staels B; van de Sluis B; Kuipers F
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1045-1069. PubMed ID: 33309945
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition.
Verkade E; Shen W; Hovingh MV; Mulder NL; de Bruyn K; Koehorst M; de Vries HD; Bloks VW; Kuipers F; de Boer JF
Clin Sci (Lond); 2023 Nov; 137(21):1637-1650. PubMed ID: 37910096
[TBL] [Abstract][Full Text] [Related]
9. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.
Honda A; Miyazaki T; Iwamoto J; Hirayama T; Morishita Y; Monma T; Ueda H; Mizuno S; Sugiyama F; Takahashi S; Ikegami T
J Lipid Res; 2020 Jan; 61(1):54-69. PubMed ID: 31645370
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
[TBL] [Abstract][Full Text] [Related]
12. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
[TBL] [Abstract][Full Text] [Related]
13. Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70
de Vries HD; Palmiotti A; Li R; Hovingh MV; Mulder NL; Koehorst M; Bloks VW; van Zutphen T; Kuipers F; de Boer JF
Pediatr Res; 2023 May; 93(6):1582-1590. PubMed ID: 36151295
[TBL] [Abstract][Full Text] [Related]
14. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
[TBL] [Abstract][Full Text] [Related]
15. Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition.
Sjöland W; Wahlström A; Makki K; Schöler M; Molinaro A; Olsson L; Greiner TU; Caesar R; de Boer JF; Kuipers F; Bäckhed F; Marschall HU
Clin Sci (Lond); 2023 Jul; 137(13):995-1011. PubMed ID: 37384590
[TBL] [Abstract][Full Text] [Related]
16. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
[TBL] [Abstract][Full Text] [Related]
17. A human-like bile acid pool induced by deletion of hepatic
de Boer JF; Verkade E; Mulder NL; de Vries HD; Huijkman N; Koehorst M; Boer T; Wolters JC; Bloks VW; van de Sluis B; Kuipers F
J Lipid Res; 2020 Mar; 61(3):291-305. PubMed ID: 31506275
[TBL] [Abstract][Full Text] [Related]
18. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
Lan T; Rao A; Haywood J; Kock ND; Dawson PA
J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
[TBL] [Abstract][Full Text] [Related]
19. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption.
Jung D; Inagaki T; Gerard RD; Dawson PA; Kliewer SA; Mangelsdorf DJ; Moschetta A
J Lipid Res; 2007 Dec; 48(12):2693-700. PubMed ID: 17823457
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
